3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
12
Carcinoma, Medullary
9
Lung Neoplasms
8
Thyroid Neoplasms
7
Neoplasms
5
Neoplasm Metastasis
5
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pleural Effusion
2
Kidney Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Familial medullary thyroid carcinoma
2
Fallopian Tube Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid cancer, medullary
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Small Cell Lung Carcinoma
1
Recurrence
1
Rectal Neoplasms
1
Precancerous Conditions
1
Peritoneal Neoplasms
1
Oligodendroglioma
1
Multiple Endocrine Neoplasia Type 2b
1
Multiple Endocrine Neoplasia Type 2a
1
Interventions
Cyclophosphamide
18
Trastuzumab
16
Paclitaxel
15
Taxes
11
Doxorubicin
11
Radiotherapy
7
Lapatinib
6
Albumin-Bound Paclitaxel
6
Vorinostat
5
Tamoxifen
5
Docetaxel
5
Carboplatin
5
Capecitabine
5
Bevacizumab
5
Radiation
4
Letrozole
4
Immunohistochemistry
4
Anastrozole
4
sargramostim
3
pegfilgrastim
3
exemestane
3
Magnetic Resonance Spectroscopy
3
Immunoenzyme Techniques
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Granulocyte Colony-Stimulating Factor
3
Fluorodeoxyglucose F18
3
Flow Cytometry
3
Filgrastim
3
Chemotherapy, Adjuvant
3
saponin QA-21V1
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms, Male
×
vandetanib
×
Clear all
No trials found.